Some session topics to be determined by participant survey responses. This schedule is subject to change. Meeting Agenda
Tuesday, November 30
Opens at 7 AM Breakfast Allgauer’s
8:30 - 8:45 AM Welcome
Birch/Oak Timothy D. Fensky, RPh, DPh, FACA, NABP Chairperson 8:45 - 10:30 AM Joint Compliance Officer/Legal Counsel Session
Birch/Oak
What’s Going on in Digital Health Care?
Moderator: Timothy D. Fensky, RPh, DPh, FACA, NABP Chairperson Telepharmacy – Has Regulation Advanced Too Much?
Panelists: Sue Mears, RPh, Compliance Officer, Iowa Board of Pharmacy
Tyler Laetsch, PharmD, RPh, Pharmacy Inspector, South Dakota State Board of Pharmacy
Truman Leong, PharmD, RPh, Compliance Officer, Arizona State Board of Pharmacy
Discussion
Online Pharmacy Trends
Panelists: Justin Macy, PharmD, JD, NABP Digital Health Senior Manager Niamh Lewis, JD, NABP Digital Health Regulatory Expert Discussion
Telehealth – Remote Clinical Services, Processing, and Dispensing Panelists: Justin Macy, PharmD, JD, NABP Digital Health Senior Manager
Niamh Lewis, JD, NABP Digital Health Regulatory Expert Discussion
10:30 - 11 AM Refreshment Break
11 AM - Noon Joint Compliance Officer/Legal Counsel Shared Discussion Topics
Birch/Oak Moderator: Jeffrey J. Mesaros, PharmD, JD, RPh, Member, NABP Executive Committee Noon - 1 PM Lunch
Hickory
1 - 2:15 PM Joint Compliance Officer/Legal Counsel Session Birch/Oak
Mixing It Up – Let’s Talk About Compounding
Moderator: Timothy D. Fensky, RPh, DPh, FACA, NABP Chairperson ISN/MOU Update
Panelists: Melissa Madigan, PharmD, JD, NABP Associate Executive Director, Professional Affairs
Jason Smith, Senior Investigator/Inspector, North Carolina Board of Pharmacy
Some session topics to be determined by participant survey responses. This schedule is subject to change.
Tony Qi, PharmD, RPh, Section Supervisor, Supervising Investigator, New Jersey Attorney General’s Office
Discussion
Physician and Veterinary Compounding
Panelists: Jenni Wai, MBA, RPh, Chief Pharmacist, State of Ohio Board of Pharmacy
Peg Panella-Spangler, MS, RPh, RD, FASHP, Supervising Inspector, California State Board of Pharmacy
Linda Bethman, JD, Assistant Attorney General, Maryland Department of Health
Discussion 2:15 - 2:45 PM Refreshment Break
2:45 - 4 PM Joint Compliance Officer/Legal Counsel Session
Birch/Oak Moderator: Tejal J. Patel, MBA, PharmD, RPh, Member, NABP Executive Committee What’s the Buzz in Medical Marijuana Cases – Investigation to Hearing?
Panelists: Amy Branson, PharmD, RPh, Pharmacy Inspector, Virginia Board of Pharmacy
Becky Parker, RPh, Pharmacist Compliance Officer, Louisiana Board of Pharmacy
Eric A. Griffin, Director of Compliance and Enforcement, State of Ohio Board of Pharmacy
Discussion
4 - 5 PM Free Time
5 - 6:45 PM Dinner
Garden Terrace
5:10 PM President’s Welcome Remarks
Caroline D. Juran, BSPharm, DPh (Hon), NABP President
Wednesday, December 1 Opens at 7 AM Breakfast Allgauer’s
8:30 - 9:30 AM Compliance Officer Session
Birch/Oak Moderator: Shane R. Wendel, PharmD, RPh, Member, NABP Executive Committee Advancing Workplace Safety and Well-Being
Panelists: Joanne M. Trifone, RPh, Director of Pharmacy Investigations, Massachusetts Board of Registration in Pharmacy
Cheryl Fox, RPh, Compliance Officer, Oregon State Board of Pharmacy Marjan Fardadfard, PharmD, DPh, BCGP, Compliance Officer,
Oklahoma State Board of Pharmacy Discussion
8:30 - 9:30 AM Legal Counsel Session
Linden 1&2 Moderator: Deborah C. Mack RPh, CHC, CCEP, Member, NABP Executive Committee Case Law Review
Panelists: Gretchen Mrozinski, JD, Lead Attorney, Wisconsin Department of Safety and Professional Services
Hans Anderson, JD, Assistant Attorney General, Minnesota State Attorney General
Daryl Hylton, JD, Legal Counsel, Missouri Board of Pharmacy Christopher Dierlam, MBA, JD, Assistant Attorney General, Florida Office of Attorney General
Kristina Jarvis, JD, Deputy Attorney General, California Attorney General Discussion
Some session topics to be determined by participant survey responses. This schedule is subject to change. 9:30 - 10:30 AM Compliance Officer Shared Discussion Topics
Birch/Oak Moderator: Nicole L. Chopski, PharmD, BCGP, ANP, Member, NABP Executive Committee 9:30 - 10:30 AM Legal Counsel Session
Linden 1&2 Moderator: Fred M. Weaver, RPh, Member, NABP Executive Committee Vaccinators, Emergency Rules, and Federal PREP Act
Panelists: Luke Daniel, JD, General Counsel, Arkansas State Board of Pharmacy Laura Steffensmeier, JD, Assistant Attorney General, Office of Attorney General of Iowa
Discussion
Shared Discussion Topics 10:30 - 10:50 AM Refreshment Break
10:50 AM - Noon Compliance Officer Session
Birch/Oak Moderator: Lenora S. Newsome, PD, NABP Treasurer
Vaccinators, Emergency Rules, and Federal PREP Act
Panelists: Zaneta Nunnally, PhT, Compliance Director, Indiana Board of Pharmacy Terri Burrows, PharmD, RPh, Compliance Officer, Texas State Board of Pharmacy
Shannon Ridge, Compliance Officer, Wyoming State Board of Pharmacy Discussion
10:50 AM - Noon Legal Counsel Session
Linden 1&2 Moderator: Bradley S. Hamilton, BSPharm, RPh, Member, NABP Executive Committee Attorney View – Bringing a Case Before the Board of Pharmacy: Complaint Screening, Probable Cause, Hearing
Panelists: Jessica Krug, JD, Deputy Attorney General, Office of the Indiana Attorney General
Amanda Cassidy, JD, Assistant Section Chief, Licensing Enforcement, Office of the Indiana Attorney General
Nicole Schuster, JD, NABP Staff Attorney Discussion
Noon - 12:45 PM Lunch Hickory
12:45 - 1:30 PM Joint Compliance Officer/Legal Counsel Session
Birch/Oak Moderator: Caroline D. Juran, BSPharm, DPh (Hon), NABP President Advancing the Implementation of the DSCSA
Panelists: Connie Jung, PhD, RPh, Senior Advisor for Policy, Office of Drug Security, Integrity, and Response, Office of Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration
Gregg Jones, RPh, NABP Compliance Senior Manager Discussion
1:30 - 2:30 PM Joint Compliance Officer/Legal Counsel Shared Discussion Topics Birch/Oak Moderator: Reginald B. “Reggie” Dilliard, DPh, NABP President-elect 2:30 - 2:50 PM Closing Remarks
Birch/Oak Reginald B. “Reggie” Dilliard, DPh, NABP President-elect
2:50 PM Meeting Adjourns
3 PM Shuttle to airport departs
Shared Discussion Topics
Tuesday, November 30
11 AM - Noon Joint Compliance Officer/Legal Counsel Shared Discussion Topics
Moderator: Jeffrey J. Mesaros, PharmD, JD, RPh, Member, NABP Executive Committee
White/brown/clear bagging
Automation “waste” due to automatic refills
Ivermectin, hydroxychloroquine, and clinical judgment
Vaccine errors
Upgraded active pharmaceutical ingredients and legal ramifications for compounding
FDA guidance documents for hospital compounding
Institutional permits and transfer of medications between permits
Wednesday, December 1
9:30 - 10:30 AM Compliance Officer Shared Discussion Topics
Moderator: Nicole L. Chopski, PharmD, BCGP, ANP, Member, NABP Executive Committee
Drug diversion trends
Increase in stimulant prescribing/dispensing
Biennial CS inventory for DEA registrants stocking emergency cabinets and nursing home automated dispensing systems
DEA/board inspector impersonators
Expanded pharmacy technician role/duties
Appropriate inspection tool for 503B outsourcing facilities
Virtual inspections
9:30 - 10:30 AM Legal Counsel Shared Discussion Topics
Moderator: Fred M. Weaver, RPh, Member, NABP Executive Committee
Legal handling – DEA/board inspector impersonation
Legal authority to discipline expired, inactive, or non-renewed licenses
If a license is in suspended or revoked status and the underlying period of licensure expires, does the board or college publish the license status as suspended, revoked, or expired?
Are board prosecutors or umbrella agency directors able to supersede or override a board order? What is the procedure?
Interesting cases pending before the board or on judicial review or appeal
1:30 - 2:30 PM Joint Compliance Officer/Legal Counsel Shared Discussion Topics Moderator: Reginald B. “Reggie” Dilliard, DPh, NABP President-elect
Physician dispensing and inspections
Pharmacies selling medications to practitioners for “office use”
Effect of COVID-19 on workplace conditions
Staffing shortages and temporary pharmacy closures
Retail limits on prescriptions dispensed per day
Decrease in patient access due to pharmacists’ workload
